A clinician hands you a prescription for estradiol to treat your hot flashes, and there is a second medication on it: progesterone. You came in for one hormone and you are leaving with two. The second one is not an upsell or an afterthought. If you still have your uterus, progesterone is the safety partner that makes systemic estrogen in hormone therapy safe to take. This post explains why the pairing is mandatory, and what the difference is between the progesterone options you may be offered.
What Estrogen Does to the Uterine Lining
The lining of your uterus, the endometrium, responds to estrogen by growing. That is its normal job during a menstrual cycle. When you take systemic estrogen on its own, with nothing to oppose it, that growth signal runs unchecked. Month after month, the lining can thicken into a state called endometrial hyperplasia. Some forms of hyperplasia are benign, but others carry abnormal cells that can progress to endometrial cancer over time.
This is settled biology, not a fringe worry. Unopposed systemic estrogen in a woman with a uterus measurably raises endometrial cancer risk, and that risk climbs with dose and duration. It is the reason the endometrial cancer warning stayed in the boxed warning for estrogen-alone products even after the FDA removed the rest of the box in November 2025. The agency did not touch the endometrial warning because the underlying risk has not changed.
What Progesterone Does About It
Progesterone (and the synthetic progestins that mimic it) opposes estrogen at the endometrium. It tells the lining to stop proliferating and to mature instead, and on cyclic schedules it triggers a shed. With adequate progestogen on board, the overgrowth does not happen, and the endometrial cancer risk of estrogen therapy is brought back down toward baseline.
This is why the pairing is non-negotiable for anyone with a uterus on systemic estrogen. It is not about symptom relief. Progesterone is there to protect an organ. The dose and schedule have to be adequate, which is why this is a prescriber decision and not something to improvise.
The One Exception
There is exactly one group that takes estrogen without progesterone: women who have had a hysterectomy. No uterus means no endometrial lining to protect, and adding a progestogen would only add side effects with no benefit. If you have had your uterus removed, estrogen alone is appropriate. Everyone else who takes systemic estrogen needs the partner drug.
A note on local vaginal estrogen, which is a different product. Low-dose vaginal estrogen for dryness and genitourinary symptoms acts locally with very little absorption into the bloodstream, and standard low doses generally do not require progesterone opposition. That is a separate product line from the systemic estradiol covered here. Ask specifically if you are unsure which you are taking.
Micronized Progesterone vs Synthetic Progestins
Not all progestogens are the same, and the choice matters for how you feel and possibly for your long-term risk profile.
Micronized progesterone
This is body-identical progesterone, the same molecule your ovaries make, processed into a fine particle size so it absorbs when taken by mouth. Brand name Prometrium, also available as a generic. It is the progestogen most major menopause guidelines prefer when there is no reason to choose otherwise. It tends to be well tolerated, and a useful side effect is drowsiness, which is why it is dosed at bedtime and can help with the disrupted sleep many women have in menopause.
Synthetic progestins
Older combined therapies used synthetic progestins such as medroxyprogesterone acetate (MPA) or norethindrone. These are effective at protecting the endometrium, which is what they are for. The concern raised by the Women's Health Initiative was that the estrogen-plus-MPA arm showed a small increase in breast cancer signal over time, while the estrogen-alone arm did not. That has fed an ongoing question about whether the progestin component, not the estrogen, carries part of the breast risk in combined therapy.
Where the evidence points
Observational data, including the large French E3N cohort (Fournier et al., Breast Cancer Res Treat 2008), suggested that estrogen combined with micronized progesterone carried a lower breast cancer signal than estrogen combined with certain synthetic progestins, at least over the first several years of use. This evidence is observational, not from a randomized trial, so it should be read as suggestive rather than settled. It is part of why micronized progesterone is the common first choice. The Menopause Society's 2022 position statement supports micronized progesterone as a preferred option for endometrial protection.
Dosing and What to Expect
Micronized progesterone for a woman with a uterus is usually given one of two ways. Continuous dosing is 100 mg nightly every night, which most women prefer because it avoids a monthly bleed. Cyclic dosing is 200 mg nightly for 12 days each month, which produces a scheduled bleed. The continuous route is common after menopause; the cyclic route is sometimes used closer to the transition.
Common side effects are drowsiness, which is the reason for bedtime dosing, and some bloating. One practical point: standard micronized progesterone capsules are suspended in peanut oil, so a true peanut allergy is a reason to ask about an alternative, which may be a compounded formulation.
The Bleeding Rule That Overrides Everything
Whatever schedule you are on, any bleeding that is unexpected for your regimen needs to be reported. On continuous therapy, some irregular spotting in the first few months is common, but new or persistent bleeding, and any bleeding after a stretch with none, deserves assessment to rule out an endometrial problem. Progesterone lowers endometrial risk; it does not make bleeding something to ignore.
The Bottom Line
If you have a uterus and you take systemic estrogen, you take progesterone too. It protects the uterine lining from the overgrowth that estrogen alone can drive. Micronized progesterone is the usual first choice, body-identical and generally well tolerated, with a side benefit for sleep. The only women who skip it are those without a uterus. This is the one rule in hormone therapy that does not bend.
Reviewed By
[Reviewed by: clinician name, credential. Last reviewed: date.]
Have questions about which progesterone is right for you? Start an intake and a licensed clinician will review your history and build a regimen that protects your uterine lining.
This article is for education and is not a substitute for individual medical advice from your own clinician.